EUVIMEDEUVIMED entdecken
Kohortenstudie

The PROPHER study: patient‐reported outcomes after parastomal hernia treatment—a prospective international cohort study

PROPHER Study Collaborating Group

Colorectal Disease · 2024

DOI: 10.1111/codi.16859 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Colorectal Disease, 2024. Verfasst von PROPHER Study Collaborating Group. Beteiligte Einrichtung: University of Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: Incisional Hernia, Surgical Stomas, Hernia, Ventral. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Bowel Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

A significant proportion of stoma patients develop a parastomal hernia (PSH), with reported rates varying widely from 5% to 50% due to heterogeneity in the definition and mode of diagnosis. PSHs are symptomatic in 75% of these patients, causing a significant impact on quality of life due to issues with appliance fitting, leakage, skin excoriation and pain. They can also lead to emergency presentations with strangulation and obstruction. Evidence is lacking on how to select patients for surgical intervention or conservative treatment. In those who do undergo surgery, the best operation for a particular patient or PSH is not always clear and many options exist. The aim of this study is to assess the impact of an individual patient’s PSH treatment on their subsequent self‐reported outcomes including treatment success and quality of life.

Methods

This is a prospective international cohort study of PSH treatment, including both operative and non‐operative interventions. A global network of clinicians and specialist nurses will recruit 1000–1500 patients and centralize detailed information, their individual background and their PSH treatment, as well as short‐term outcomes up to 30 days. Patients will then provide their own outcomes data including quality of life and whether their treatment was successful, via a secure online system, at 3, 6 and 12 months. PROPHER will be run in two phases: an internal pilot phase of at least 10 hospitals from up to five countries, and a main phase of up to 200 hospitals from across the European Society of Coloproctology network.

Discussion

This study will provide a wealth of contemporaneous information which will improve our ability to counsel patients and facilitate improved selection of appropriate and personalized interventions for those with a PSH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Incisional HerniaSurgical StomasHernia, VentralHumansQuality of LifeProspective StudiesCohort StudiesColostomyPatient Reported Outcome MeasuresSurgical Mesh

Stichwörter der Autor:innen

conservative treatmentparastomal herniapatient‐reported outcome measuressurgical repair

Autor:innen und Institutionen

  • University of Birmingham, Birmingham, UK.

Förderung

  • Bowel Research UK

Zitieren

APA

PROPHER Study Collaborating Group (2024). The PROPHER study: patient‐reported outcomes after parastomal hernia treatment—a prospective international cohort study. Colorectal Disease. https://doi.org/10.1111/codi.16859

Vancouver

PROPHER Study Collaborating Group. The PROPHER study: patient‐reported outcomes after parastomal hernia treatment—a prospective international cohort study. Colorectal Disease. 2024. doi:10.1111/codi.16859

BibTeX
@article{PROPHERStudyCollaboratingGroup2024,
  author = {PROPHER Study Collaborating Group, PROPHER Study Collaborating Group},
  title = {The PROPHER study: patient‐reported outcomes after parastomal hernia treatment—a prospective international cohort study},
  journal = {Colorectal Disease},
  year = {2024},
  doi = {10.1111/codi.16859}
}
Kostenlos starten →